Suchergebnisse - "Hu, Huabin"

PubPharm (156)

81

Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer

enthalten in: Advances in therapy | 2020

von Ding, D. | Hu, H. | Liao, M. | +6

82

Advances in exploring activity cliffs

enthalten in: Journal of computer aided molecular design | 2020

von Stumpfe, D. | Hu, H. | Bajorath, J.

83

Advances in exploring activity cliffs

enthalten in: Journal of computer aided molecular design | 2020

von Stumpfe, D. | Hu, H. | Bajorath, J.

84

Advances in exploring activity cliffs

enthalten in: Journal of computer aided molecular design | 2020

von Stumpfe, D. | Hu, H. | Bajorath, J.

85

Increasing the public activity cliff knowledge base with new categories of activity cliffs

enthalten in: Future science OA | 2020

von Hu, H. | Bajorath, J.

86

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer

enthalten in: Nature communications | 2020

von Qin, G. | Wang, X. | Ye, S. | +18

87

Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer

enthalten in: Advances in therapy | 2020

von Ding, D. | Hu, H. | Liao, M. | +6

88

Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer

enthalten in: Advances in therapy | 2020

von Ding, D. | Hu, H. | Liao, M. | +6

89

Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer

enthalten in: Advances in therapy | 2020

von Ding, D. | Hu, H. | Liao, M. | +6

90

Systematic Exploration of Activity Cliffs Containing Privileged Substructures

enthalten in: Molecular pharmaceutics | 2020

von Hu, H. | Bajorath, J.